[1] Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache J Headache Pain. 2018 Aug 7;19(1):64. DOI:
10.1186/s10194-018-0893-8[2] Hoffmann J, et al. PAC-1 receptor antibody modulates nociceptive trigeminal activity in rat. Cephalalgia. 2016;36(1S):141–141.